357
Participants
Start Date
June 30, 2006
Primary Completion Date
February 29, 2008
Study Completion Date
February 29, 2008
Fluticasone propionate/Formoterol Fumarate 100/10
FlutiForm 100/10ug is a HFA pMDI that delivers 50ug of Fluticasone propionate per actuation and 5ug of Formoterol fumarate per actuation. Patients will take 2 actuations BID for 12 weeks.
Fluticasone propionate 100
Fluticasone 100 is a HFA pMDI that delivers 50ug of Fluticasone propionate per actuation. Patients will take 2 actuations BID for 12 weeks.
Formoterol fumarate 10
Formoterol 10ug is a HFA pMDI that delivers 5ug of Formoterol fumarate per actuation. Patients will take 2 actuations BID for 12 weeks.
Research Center, Rochester
Research Site, Easton
Research Site, Bethesda
Research Site, Raleigh
Research Site, Asheville
Research Site, Greenville
Research Site, Lilburn
Research Site, Savannah
Research Site, Birmingham
Research Site, Chattanooga
Research Site, Sylvania
Research Site, Cincinnati
Research Center, Stevensville
Research Site, Greenfield
Research Site, Park City
Research Site, Waco
Research Site, Houston
Research Site, Katy
Research Site, New Braunfels
Research Site, El Paso
Research Site, Denver
Research Site, Vista
Research Site, Mission Viejo
Research Site, Orange
Research Site, San Jose
Research Site, North Dartmouth
Research Site, Elizabeth
Research Site, Lincoln
Research Site, South Burlington
Research Site, Kelowna
Research Site, Vancouver
Research Site, Hamilton
Research Center, London
Research Site, London
Research Site, Mississauga
Research Site, Oshawa
Research Site, Toronto
Research Site, Longueuil
Research Site, Montreal
Research Site, Saint Foy
Research Site, Trois-Rivières
SkyePharma AG
INDUSTRY